Prime Capital Investment Advisors’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.5K | Sell |
20,372
-9,927
| -33% | -$20.2K | ﹤0.01% | 927 |
|
|
2025
Q1 | $49.4K | Sell |
30,299
-991
| -3% | -$1.62K | ﹤0.01% | 1023 |
|
|
2024
Q4 | $57.3K | Buy |
+31,290
| New | +$57.3K | ﹤0.01% | 908 |
|
|
2024
Q3 | – | Sell |
-10,036
| Closed | -$81.1K | – | 933 |
|
|
2024
Q2 | $81.1K | Sell |
10,036
-136
| -1% | -$1.1K | ﹤0.01% | 888 |
|
|
2024
Q1 | $141K | Sell |
10,172
-747
| -7% | -$10.4K | ﹤0.01% | 945 |
|
|
2023
Q4 | $66.8K | Sell |
10,919
-662
| -6% | -$4.05K | ﹤0.01% | 927 |
|
|
2023
Q3 | $54.1K | Buy |
11,581
+7,886
| +213% | +$36.8K | ﹤0.01% | 734 |
|
|
2023
Q2 | $19.8K | Buy |
3,695
+795
| +27% | +$4.26K | ﹤0.01% | 761 |
|
|
2023
Q1 | $28.5K | Buy |
+2,900
| New | +$28.5K | ﹤0.01% | 543 |
|
|
2020
Q2 | – | Sell |
-109
| Closed | -$10K | – | 486 |
|
|
2020
Q1 | $10K | Buy |
+109
| New | +$10K | ﹤0.01% | 403 |
|